Compugen to Present at Jefferies 2013 Global Healthcare Conference
May 27 2013 - 6:00AM
Business Wire
Compugen Ltd. (NASDAQ: CGEN) today announced that its Chairman
of the Board, Martin S. Gerstel, will be presenting at the
Jefferies 2013 Global Healthcare Conference, on Monday, June 3 at
12:30 PM ET, at the Grand Hyatt in New York.
About Compugen
Compugen is a leading drug discovery company focused on
therapeutic proteins and monoclonal antibodies to address important
unmet needs in the fields of immunology and oncology. The
Company utilizes a broad and continuously growing integrated
infrastructure of proprietary scientific understandings and
predictive platforms, algorithms, machine learning systems and
other computational biology capabilities for the in
silico (by computer) prediction and selection of product
candidates, which are then advanced in its Pipeline Program. The
Company's business model includes collaborations covering the
further development and commercialization of selected product
candidates from its Pipeline Program and various forms of research
and discovery agreements, in both cases providing Compugen with
potential milestone payments and royalties on product sales or
other forms of revenue sharing. In 2012, Compugen established
operations in California for the development of oncology and
immunology monoclonal antibody therapeutic candidates against
Compugen drug targets. For additional information, please visit
Compugen's corporate website at www.cgen.com.
Compugen (NASDAQ:CGEN)
Historical Stock Chart
From Sep 2024 to Oct 2024
Compugen (NASDAQ:CGEN)
Historical Stock Chart
From Oct 2023 to Oct 2024